MX2009010894A - Derivados de 3-hidroquinazolin-4-ona para utilizarse como inhibidores de estearoil-coa-desaturasa. - Google Patents
Derivados de 3-hidroquinazolin-4-ona para utilizarse como inhibidores de estearoil-coa-desaturasa.Info
- Publication number
- MX2009010894A MX2009010894A MX2009010894A MX2009010894A MX2009010894A MX 2009010894 A MX2009010894 A MX 2009010894A MX 2009010894 A MX2009010894 A MX 2009010894A MX 2009010894 A MX2009010894 A MX 2009010894A MX 2009010894 A MX2009010894 A MX 2009010894A
- Authority
- MX
- Mexico
- Prior art keywords
- coa desaturase
- hydroquinazolin
- derivatives
- stearoyl
- stearoyl coa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invención da a conocer derivados de 3-hidroquinazolin-4-ona para utilizarse como inhibidores de la estearoil-CoA-desaturasa. Los compuestos son útiles en el tratamiento y/o en la prevención de diferentes enfermedades humanas mediadas por las enzimas de estearoil-CoA-desaturasa (SCD), en especial las enfermedades relacionadas con niveles anormales de lípidos, cáncer, enfermedad cardiovascular, diabetes, obesidad, síndrome metabólico, y similares.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91122507P | 2007-04-11 | 2007-04-11 | |
PCT/US2008/004632 WO2008127615A1 (en) | 2007-04-11 | 2008-04-10 | 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009010894A true MX2009010894A (es) | 2009-10-26 |
Family
ID=39709340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009010894A MX2009010894A (es) | 2007-04-11 | 2008-04-10 | Derivados de 3-hidroquinazolin-4-ona para utilizarse como inhibidores de estearoil-coa-desaturasa. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20080255161A1 (es) |
EP (1) | EP2155695A1 (es) |
JP (1) | JP2010523674A (es) |
KR (1) | KR20100016421A (es) |
CN (1) | CN101652353A (es) |
AU (1) | AU2008239689A1 (es) |
BR (1) | BRPI0809551A2 (es) |
CA (1) | CA2683925A1 (es) |
IL (1) | IL201117A0 (es) |
MX (1) | MX2009010894A (es) |
RU (1) | RU2009141596A (es) |
WO (1) | WO2008127615A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2066665A2 (en) * | 2006-10-05 | 2009-06-10 | Cv Therapeutics, Inc. | Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors |
JP2010523653A (ja) * | 2007-04-09 | 2010-07-15 | ギリアード・パロ・アルト・インコーポレイテッド | ステアロイルCoAデサチュラーゼのインヒビターとして使用するためのプテリジノン誘導体 |
US20090105283A1 (en) * | 2007-04-11 | 2009-04-23 | Dmitry Koltun | 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
WO2009089277A2 (en) | 2008-01-08 | 2009-07-16 | The Trustees Of The University Of Pennsylvania | Rel inhibitors and methods of use thereof |
MX2010010949A (es) * | 2008-04-04 | 2011-02-22 | Gilead Sciences Inc | Derivados de triazolopiridinona para utilizarse como inhibidores de desaturasa de estearoilo coa. |
WO2009124259A1 (en) * | 2008-04-04 | 2009-10-08 | Cv Therapeutics, Inc. | Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors |
WO2010045374A1 (en) * | 2008-10-15 | 2010-04-22 | Gilead Palo Alto, Inc. | 3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors |
BR112014008590A2 (pt) | 2011-10-15 | 2017-10-24 | Genentech Inc | métodos de uso de antagonistas de scd1 |
EP2842946B1 (en) | 2012-04-24 | 2016-09-28 | Chugai Seiyaku Kabushiki Kaisha | Quinazolinedione derivative |
US9695118B2 (en) | 2012-04-24 | 2017-07-04 | Chugai Seiyaku Kabushiki Kaisha | Benzamide derivative |
CN105829285A (zh) * | 2013-10-23 | 2016-08-03 | 中外制药株式会社 | 喹唑啉酮和异喹啉酮衍生物 |
SG11201708622UA (en) | 2015-02-02 | 2017-11-29 | Forma Therapeutics Inc | 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors |
WO2016126726A1 (en) | 2015-02-02 | 2016-08-11 | Forma Therapeutics, Inc. | Bicyclic [4,6,0] hydroxamic acids as hdac6 inhibitors |
EP3472131B1 (en) | 2016-06-17 | 2020-02-19 | Forma Therapeutics, Inc. | 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors |
EP3529245A4 (en) | 2016-10-24 | 2020-12-23 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES OF THE LATEST |
EP3566055A4 (en) | 2017-01-06 | 2020-12-02 | Yumanity Therapeutics, Inc. | TREATMENT METHODS FOR NEUROLOGICAL DISORDERS |
EP3700934A4 (en) | 2017-10-24 | 2021-10-27 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES OF THESE COMPOUNDS |
CN110903253B (zh) * | 2019-12-13 | 2020-12-25 | 西安交通大学医学院第一附属医院 | 一种喹唑啉酮类化合物及其制备方法和应用 |
CN113354590A (zh) * | 2020-03-05 | 2021-09-07 | 宁波康柏睿格医药科技有限公司 | 拮抗nod1/2受体信号通路的喹唑啉酮类化合物 |
KR20230119124A (ko) | 2020-11-13 | 2023-08-16 | 이니팜, 인크. | 디클로로페놀 hsd17b13 억제제 및 이의 용도 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
JPS5920668B2 (ja) * | 1975-10-03 | 1984-05-15 | 田辺製薬株式会社 | キナゾリン誘導体の製法 |
JPS5920670B2 (ja) * | 1976-04-10 | 1984-05-15 | 田辺製薬株式会社 | キナゾリノン誘導体の製法 |
US4326525A (en) * | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
US5364620A (en) * | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
US5023252A (en) * | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
US5001139A (en) * | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
US4992445A (en) * | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
US4902514A (en) * | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
CA2020073A1 (en) * | 1989-07-03 | 1991-01-04 | Eric E. Allen | Substituted quinazolinones as angiotensin ii antagonists |
JP3488890B2 (ja) * | 1993-11-09 | 2004-01-19 | アグロカネショウ株式会社 | 3−n−置換キナゾリノン誘導体、その製造法および該化合物を含有する除草剤 |
ATE198593T1 (de) * | 1995-08-02 | 2001-01-15 | Uriach & Cia Sa J | Pyrimidonderivate mit antifungaler wirkung |
US6638937B2 (en) * | 1998-07-06 | 2003-10-28 | Bristol-Myers Squibb Co. | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
IL140622A0 (en) * | 1998-07-06 | 2002-02-10 | Bristol Myers Squibb Co | Biphenyl sufonamide derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof |
US6562830B1 (en) * | 1999-11-09 | 2003-05-13 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with phenyl quinazolinone derivatives |
US6894057B2 (en) * | 2002-03-08 | 2005-05-17 | Warner-Lambert Company | Oxo-azabicyclic compounds |
WO2003106435A1 (en) * | 2002-06-18 | 2003-12-24 | Sankyo Company, Limited | Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof |
US20040142950A1 (en) * | 2003-01-17 | 2004-07-22 | Bunker Amy Mae | Amide and ester matrix metalloproteinase inhibitors |
JP2006193426A (ja) * | 2003-09-05 | 2006-07-27 | Sankyo Co Ltd | 置換された縮環ピリミジン−4(3h)−オン化合物 |
CA2547284A1 (en) * | 2003-11-28 | 2005-06-09 | Mitsubishi Pharma Corporation | Quinazoline derivative and process for producing the same |
EP2269610A3 (en) * | 2004-09-20 | 2011-03-09 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
DK1830869T3 (da) * | 2004-12-24 | 2013-08-26 | Spinifex Pharm Pty Ltd | Fremgangsmåde til behandling eller profylakse |
EP2066665A2 (en) * | 2006-10-05 | 2009-06-10 | Cv Therapeutics, Inc. | Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors |
MX2009008099A (es) * | 2007-02-01 | 2009-12-14 | Resverlogix Corp | Compuestos para la prevencion y tratamiento de enfermedades cardiovasculares. |
JP2010523653A (ja) * | 2007-04-09 | 2010-07-15 | ギリアード・パロ・アルト・インコーポレイテッド | ステアロイルCoAデサチュラーゼのインヒビターとして使用するためのプテリジノン誘導体 |
-
2008
- 2008-04-09 US US12/100,399 patent/US20080255161A1/en not_active Abandoned
- 2008-04-10 KR KR1020097023479A patent/KR20100016421A/ko not_active Application Discontinuation
- 2008-04-10 AU AU2008239689A patent/AU2008239689A1/en not_active Abandoned
- 2008-04-10 CN CN200880011238A patent/CN101652353A/zh active Pending
- 2008-04-10 RU RU2009141596/04A patent/RU2009141596A/ru not_active Application Discontinuation
- 2008-04-10 JP JP2010503057A patent/JP2010523674A/ja active Pending
- 2008-04-10 EP EP08742725A patent/EP2155695A1/en not_active Withdrawn
- 2008-04-10 MX MX2009010894A patent/MX2009010894A/es unknown
- 2008-04-10 CA CA002683925A patent/CA2683925A1/en not_active Abandoned
- 2008-04-10 BR BRPI0809551-5A patent/BRPI0809551A2/pt not_active Application Discontinuation
- 2008-04-10 WO PCT/US2008/004632 patent/WO2008127615A1/en active Search and Examination
-
2009
- 2009-09-23 IL IL201117A patent/IL201117A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20080255161A1 (en) | 2008-10-16 |
BRPI0809551A2 (pt) | 2014-09-16 |
KR20100016421A (ko) | 2010-02-12 |
IL201117A0 (en) | 2010-05-17 |
WO2008127615A1 (en) | 2008-10-23 |
JP2010523674A (ja) | 2010-07-15 |
EP2155695A1 (en) | 2010-02-24 |
AU2008239689A1 (en) | 2008-10-23 |
RU2009141596A (ru) | 2011-05-20 |
CA2683925A1 (en) | 2008-10-23 |
CN101652353A (zh) | 2010-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009010894A (es) | Derivados de 3-hidroquinazolin-4-ona para utilizarse como inhibidores de estearoil-coa-desaturasa. | |
MX2009003658A (es) | Compuestos heterociclicos que contienen nitrogeno biciclico para utilizarse como inhibidores de desaturasa de estearoilo-coa. | |
EP2217596B8 (en) | Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 | |
MX2009011359A (es) | Derivados de pirimidinona y sus metodos de uso. | |
MX342423B (es) | Metodos para usar inhibidores de cotransportadores 1 y 2 de glucosa y sodio. | |
GEP20135724B (en) | Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for treatment or prevention of diabetes | |
AU2007221366A8 (en) | Oxyntomodulin derivatives | |
MY155695A (en) | Quinoxalinedione derivatives | |
MY155418A (en) | Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives | |
MX2009005935A (es) | Compuestos biciclicos y su uso como anti-diabeticos. | |
IL213425A0 (en) | Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase | |
CO6341563A2 (es) | Compuestos organicos | |
WO2007084314A3 (en) | MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | |
MX356584B (es) | Analogos de tiazolidindiona para el tratamiento de enfermedad mediada por inflamacion metabolica. | |
UA107783C2 (en) | Isoindoline compounds for use in treating cancer | |
MY153263A (en) | Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levels | |
MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
MY149957A (en) | Heterocyclic inhibitors of mek and methods of use thereof | |
MX2009012920A (es) | Compuestos heptaciclicos y usos farmaceuticos de los mismos para la prevencion y tratamiento de diabetes y sindrome metabolico. | |
MX2008011633A (es) | Aminoquinolonas como inhibidores de gsk-3. | |
MX2010009883A (es) | Acidos dicarboxilicos de cadena media, sus derivados y enfermedades metabolicas. | |
HK1124863A1 (en) | Inhibitors of sodium glucose co-transporter 2 and methods of their use | |
MX2011006006A (es) | Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos. | |
MX360554B (es) | Composiciones que comprenden y metodos que utilizan inhibidores de co-transportadores de glucosa-sodio 1 y 2. | |
EP2061456A4 (en) | COMPOSITIONS AND METHODS FOR INHIBITING P450 CYTOCHROME |